[HTML][HTML] An umbrella review of the evidence linking oral health and systemic noncommunicable diseases

J Botelho, P Mascarenhas, J Viana, L Proença… - Nature …, 2022 - nature.com
Oral diseases are highly prevalent worldwide. Recent studies have been supporting a
potential bidirectional association of oral diseases with systemic noncommunicable …

[HTML][HTML] Adverse health effects of emerging contaminants on inflammatory bowel disease

X Chen, S Wang, X Mao, X Xiang, S Ye… - Frontiers in Public …, 2023 - frontiersin.org
Inflammatory bowel disease (IBD) is becoming increasingly prevalent with the improvement
of people's living standards in recent years, especially in urban areas. The emerging …

[HTML][HTML] Trends in the incidence and prevalence of end-stage kidney disease requiring dialysis in Taiwan: 2010–2018

TS Lai, CC Hsu, MH Lin, VC Wu, YM Chen - Journal of the Formosan …, 2022 - Elsevier
Background/Purpose Taiwan has the highest incidence and prevalence of end-stage kidney
disease (ESKD) worldwide. However, the epidemiologic features of ESKD requiring dialysis …

[PDF][PDF] Taiwan Biobank: A rich biomedical research database of the Taiwanese population

YCA Feng, CY Chen, TT Chen, PH Kuo, YH Hsu… - Cell Genomics, 2022 - cell.com
Summary The Taiwan Biobank (TWB) is an ongoing prospective study of> 150,000
individuals aged 20–70 in Taiwan. A comprehensive list of phenotypes was collected for …

Accuracy of Japanese claims data in identifying diabetes‐related complications

K Fujihara, M Yamada‐Harada… - … and Drug Safety, 2021 - Wiley Online Library
Purpose To evaluate the accuracy of various claims‐based definitions of diabetes‐related
complications (coronary artery disease [CAD], heart failure, cerebrovascular disease and …

Association of glucagon-like peptide-1 receptor agonist vs dipeptidyl peptidase-4 inhibitor use with mortality among patients with type 2 diabetes and advanced …

JJ Chen, CY Wu, CC Jenq, TH Lee, CY Tsai… - JAMA Network …, 2022 - jamanetwork.com
Importance Glucagon-like peptide-1 (GLP-1) receptor agonist use is associated with
reduced mortality and improved cardiovascular outcomes in the general population with …

[HTML][HTML] Artificial intelligence–based prediction of lung cancer risk using nonimaging electronic medical records: Deep learning approach

MCH Yeh, YH Wang, HC Yang, KJ Bai… - Journal of medical …, 2021 - jmir.org
Background Artificial intelligence approaches can integrate complex features and can be
used to predict a patient's risk of developing lung cancer, thereby decreasing the need for …

[HTML][HTML] Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors

DSH Lin, JK Lee, WJ Chen - Diabetologia, 2021 - Springer
Aims/hypothesis The safety and efficacy of glucagon-like peptide-1 receptor agonists
(GLP1RAs) and dipeptidyl peptidase-4 inhibitors (DPP4is) in major cardiovascular adverse …

Validation of diagnosis codes in healthcare databases in Taiwan, a literature review

YT Huang, T Wei, YL Huang, YP Wu… - … and drug safety, 2023 - Wiley Online Library
Purpose To compile validation findings of diagnosis codes and related algorithms for health
outcomes of interest from National Health Insurance (NHI) or electronic medical records in …

Metformin use is associated with a lower risk of inflammatory bowel disease in patients with type 2 diabetes mellitus

CH Tseng - Journal of Crohn's and Colitis, 2021 - academic.oup.com
Aim Our aim was to compare the risk of developing inflammatory bowel disease [IBD]
between ever users and never users of metformin. Methods Patients with newly diagnosed …